| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,810,000 | 3,108,000 | 3,525,000 | 3,489,000 | | Cost of Revenue | 1,725,000 | 1,972,000 | 2,221,000 | 2,181,000 | | | Gross Profit | 1,085,000 | 1,136,000 | 1,304,000 | 1,308,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 337,000 | 382,000 | 369,000 | 358,000 | | Non Recurring | 87,000 | (2,000) | (23,000) |
-
| | Others | 289,000 | 297,000 | 326,000 | 318,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 372,000 | 459,000 | 632,000 | 632,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 6,000 | 6,000 | 5,000 | | Earnings Before Interest And Taxes | 376,000 | 457,000 | 625,000 | 622,000 | | Interest Expense | 105,000 | 114,000 | 114,000 | 105,000 | | Income Before Tax | 271,000 | 343,000 | 511,000 | 517,000 | | Income Tax Expense | 101,000 | 125,000 | 201,000 | 199,000 | | Minority Interest |
-
| (8,000) | (13,000) | (13,000) | | | | Net Income From Continuing Ops | 170,000 | 218,000 | 310,000 | 318,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 170,000 | 218,000 | 310,000 | 318,000 | | Preferred Stock And Other Adjustments | (15,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $155,000 | $218,000 | $310,000 | $318,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
